199 related articles for article (PubMed ID: 30326958)
1. The role of induction chemotherapy followed by surgery in unresectable stage IVb laryngeal and hypopharyngeal cancers: a case series.
Sittitrai P; Reunmarkkaew D; Chaiyasate S
J Otolaryngol Head Neck Surg; 2018 Oct; 47(1):62. PubMed ID: 30326958
[TBL] [Abstract][Full Text] [Related]
2. Long-term Results of a Multicenter Randomized Phase III Trial of Induction Chemotherapy With Cisplatin, 5-fluorouracil, ± Docetaxel for Larynx Preservation.
Janoray G; Pointreau Y; Garaud P; Chapet S; Alfonsi M; Sire C; Jadaud E; Calais G
J Natl Cancer Inst; 2016 Apr; 108(4):. PubMed ID: 26681800
[TBL] [Abstract][Full Text] [Related]
3. [Comparative analysis of clinical efficacies between induction chemotherapy and surgery combined with radiotherapy or concurrent chemoradiotherapy in advanced hypopharyngeal carcinoma].
Li ZD; Lu T
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Dec; 53(12):918-924. PubMed ID: 30585004
[No Abstract] [Full Text] [Related]
4. Combined chemotherapy and radiotherapy versus surgery and postoperative radiotherapy for advanced hypopharyngeal cancer.
Zelefsky MJ; Kraus DH; Pfister DG; Raben A; Shah JP; Strong EW; Spiro RH; Bosl GJ; Harrison LB
Head Neck; 1996; 18(5):405-11. PubMed ID: 8864731
[TBL] [Abstract][Full Text] [Related]
5. Dose-escalated intensity-modulated radiotherapy is feasible and may improve locoregional control and laryngeal preservation in laryngo-hypopharyngeal cancers.
Miah AB; Bhide SA; Guerrero-Urbano MT; Clark C; Bidmead AM; St Rose S; Barbachano Y; A'hern R; Tanay M; Hickey J; Nicol R; Newbold KL; Harrington KJ; Nutting CM
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):539-47. PubMed ID: 21236602
[TBL] [Abstract][Full Text] [Related]
6. Definitive Chemoradiotherapy Versus Surgery Followed by Adjuvant Radiotherapy in Resectable Stage III/IV Hypopharyngeal Cancer.
Kim JW; Kim MS; Kim SH; Kim JH; Lee CG; Kim GE; Keum KC
Cancer Res Treat; 2016 Jan; 48(1):45-53. PubMed ID: 25779363
[TBL] [Abstract][Full Text] [Related]
7. Induction chemotherapy with cisplatin and 5-fluorouracil followed by chemoradiotherapy or radiotherapy alone in the treatment of locoregionally advanced resectable cancers of the larynx and hypopharynx: results of single-center study of 45 patients.
Altundag O; Gullu I; Altundag K; Yalcin S; Ozyar E; Cengiz M; Akyol F; Yucel T; Hosal S; Sozeri B
Head Neck; 2005 Jan; 27(1):15-21. PubMed ID: 15515158
[TBL] [Abstract][Full Text] [Related]
8. Chemoradiotherapy laryngeal preservation for advanced hypopharyngeal cancer.
Tai SK; Yang MH; Wang LW; Tsai TL; Chu PY; Wang YF; Huang JL; Chang SY
Jpn J Clin Oncol; 2008 Aug; 38(8):521-7. PubMed ID: 18697758
[TBL] [Abstract][Full Text] [Related]
9. Chemoselection combined with alternating chemoradiotherapy or surgery for hypopharyngeal cancer.
Matsuzuka T; Sato H; Suzuki R; Suzuki M; Saijoh S; Ikeda M; Nakaegawa Y; Tani A; Imaizumi M; Matsui T; Nomoto Y; Nomoto M; Tada Y; Suzuki Y; Omori K
Laryngoscope; 2016 Jun; 126(6):1349-53. PubMed ID: 26536058
[TBL] [Abstract][Full Text] [Related]
10. Single-cycle induction chemotherapy for resectable advanced hypopharyngeal cancer.
Nakashima T; Yasumatsu R; Asai K; Uryu H; Kogo R; Nakagawa T
Int J Clin Oncol; 2017 Jun; 22(3):442-447. PubMed ID: 28062933
[TBL] [Abstract][Full Text] [Related]
11. Concurrent chemoradiotherapy for T4 patients with hypopharyngeal and laryngeal squamous cell carcinomas.
Nishimura G; Tsukuda M; Horiuchi C; Satake K; Yoshida T; Nagao J; Kawakami M; Kondo N; Arai Y; Taguchi T; Matsuda H; Mikami Y
Auris Nasus Larynx; 2007 Dec; 34(4):499-504. PubMed ID: 17604583
[TBL] [Abstract][Full Text] [Related]
12. Treatment results and prognostic factors in locally advanced hypopharyngeal cancer.
Lee MS; Ho HC; Hsiao SH; Hwang JH; Lee CC; Hung SK
Acta Otolaryngol; 2008 Jan; 128(1):103-9. PubMed ID: 17851955
[TBL] [Abstract][Full Text] [Related]
13. Impact of indication-shift of primary and adjuvant chemo radiation in advanced laryngeal and hypopharyngeal squamous cell carcinoma.
Boehm A; Lindner F; Wichmann G; Bauer U; Wittekind C; Knoedler M; Lordick F; Dietzsch S; Scholz M; Kortmann R; Dietz A
Eur Arch Otorhinolaryngol; 2015 Aug; 272(8):2017-25. PubMed ID: 24961436
[TBL] [Abstract][Full Text] [Related]
14. [The results and toxicity of organ preservation treatment for locoregionally advanced laryngeal and hypopharyngeal cancer].
Kiprian D; Kawecki A; Jarząbski A; Michalski W; Pawłowska-Sendułka B
Otolaryngol Pol; 2011; 65(5):363-8. PubMed ID: 22078287
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of use of a single cycle of induction chemotherapy and concurrent chemoradiotherapy containing capecitabine/cisplatin followed by surgery for patients with resectable esophageal squamous cell carcinoma: long-term follow-up data.
Koo DH; Park SI; Kim YH; Kim JH; Jung HY; Lee GH; Choi KD; Song HJ; Song HY; Shin JH; Cho KJ; Yoon DH; Kim SB
Cancer Chemother Pharmacol; 2012 Mar; 69(3):655-63. PubMed ID: 21968953
[TBL] [Abstract][Full Text] [Related]
16. Squamous cell carcinoma of the hypopharynx: single-institution outcome analysis of a large cohort of patients treated with primary non-surgical approaches.
Gupta T; Chopra S; Agarwal JP; Laskar SG; D'cruz AK; Shrivastava SK; Dinshaw KA
Acta Oncol; 2009; 48(4):541-48. PubMed ID: 18979267
[TBL] [Abstract][Full Text] [Related]
17. Weekly low-dose docetaxel-based chemoradiotherapy for locally advanced oropharyngeal or hypopharyngeal carcinoma: a retrospective, single-institution study.
Fukada J; Shigematsu N; Takeda A; Ohashi T; Tomita T; Shiotani A; Kunieda E; Kawaguchi O; Fujii M; Kubo A
Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):417-24. PubMed ID: 19409727
[TBL] [Abstract][Full Text] [Related]
18. Can response to induction chemotherapy be a predictive marker for ultimate outcome in hypopharyngeal cancer?
Han MW; Ryu IS; Lee SW; Kim SB; Roh JL; Choi SH; Kim SY; Nam SY
Otolaryngol Head Neck Surg; 2012 Jan; 146(1):74-80. PubMed ID: 21896788
[TBL] [Abstract][Full Text] [Related]
19. 2-[18F]-Fluoro-2-deoxy-D-glucose positron emission tomography as guidance for primary treatment in patients with advanced-stage resectable squamous cell carcinoma of the larynx and hypopharynx.
Roh JL; Pae KH; Choi SH; Kim JS; Lee S; Kim SB; Nam SY; Kim SY
Eur J Surg Oncol; 2007 Aug; 33(6):790-5. PubMed ID: 17306956
[TBL] [Abstract][Full Text] [Related]
20. Rational choice of induction chemotherapy-based larynx preservation for hypopharyngeal cancer.
Liu S; Fang J; Ma H; Meng L; Bai Y; Feng L; Lian M; Li P; Zhong Q; Hou L
Acta Otolaryngol; 2018 Dec; 138(12):1146-1153. PubMed ID: 30663475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
